Metrion Biosciences closes £3.7m equity financing
The company announced that the funding will be used to expand Metrion’s new (2021) laboratories in Cambridge, UK, invest in specialist...
miRNA specialist Resalis Therapeutics Srl raises €10m in Series A financing
Existing investors including Claris Ventures and angel investors participated in the financing The proceeds will be used to initiate and complete the...
Novo Nordisk Foundation in US$25m partnership with CARB-X
The Novo Nordisk Foundation is committing up to US$25m to support the early-stage development of drugs, vaccines and diagnostics to prevent,...
Cathera SA closes Series B round at €42m
The Series B update was led by Unorthodox Ventures. Existing shareholders Supernova Invest, Saint-Genys and Bouscas Med also participated in the...
EU parliament backs deregulation of New Genome Techniques
With the MEPs' approval of the amendments to the European Commission's draft legislation, the way is now clear for a regulation that distinguishes...
Antabio SAS raises €25 m in Series B financing
According to Antabio SAS, the financing will be used to support the clinical development of MEM-ANT3310 to proof-of-concept. MEM-ANT3310 is a next...
Roche presents restistance-breaking antibiotic
Antibiotic resistance has become an urgent threat to global public health in recent decades....